Scientists probe gut to see how drugs really dissolve
NCT ID NCT05159427
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to understand how a modified-release diabetes drug called glipizide dissolves in the stomach and small intestine. Researchers will directly sample gut contents, blood, urine, and stool from 40 healthy volunteers after they take the drug. The goal is to improve lab models that predict drug dissolution, not to treat any condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Glipizide (a diabetes drug) in extended-release tablets and a stable isotope form
What this could lead to
If successful, this could help create better lab tests that predict how drugs dissolve in the human gut, improving future drug development.
What could go wrong
This is a very early, small study in healthy people, not patients. It focuses on measuring drug behavior, not treating any disease, so direct benefits are unlikely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN GASTROINTESTINAL PHYSIOLOGY DATA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact